Key result
ASSIST study evaluates statin impact on progression of asymptomatic aortic sclerosis and stenosis.
Why the study?
Progression of aortic valve sclerosis and stenosis is unpredictable and current medical therapies like statins and ACE inhibitors have inconclusive evidence, necessitating large prospective studies.
Observational
Yes
Answers are grounded in this paper and cite their sources.
Unpredictable aortic stenosis progression with variable patterns leaves open whether targeted medical therapy can slow disease.
Progression of sclerosis and stenosis is substantially unpredictable in the individual patient: in some cases it is very slow, in others it is accelerated. In addition, different patterns of progression (linear and non-linear) are possible. It has been suggested that the aortic valve lesion can be considered a form within the spectrum of the same atherosclerotic disease. In this context it seemed reasonable to hypothesize that targeted medical therapy could retard the progression of the disease. In particular HMG-CoA reductase inhibitors (statins) and angiotensin-converting enzyme inhibitors have been tested. The first experimental and clinical studies are now available, even though they are not conclusive to date. Large, prospective, randomized trials are ideally needed, but they are quite difficult, if not even impossible, to realize in practice. The ASSIST study (Asymptomatic aortic Sclerosis/Stenosis: Influence of STatins) of the Italian Society of Cardiovascular Echography aims to create a large, prospective, observational investigation, involving many centers of echocardiography and thousands of patients, in order to provide from the real clinical world at least some of the answers to this unsolved question.
No takes yet. Share an insight, caveat, or question.
Antonini‐Canterin et al. (2006) conducted an observational in Asymptomatic aortic sclerosis and stenosis. Statins was evaluated on Progression of aortic valve sclerosis and stenosis. Statin therapy will be evaluated in the ASSIST study, a large prospective observational investigation aiming to determine its influence on the progression of asymptomatic aortic sclerosis and stenosis.
Synapse has enriched 10 related papers. Consider them for comparative context: